MR编号 | AT/H/0959/001 |
---|
药品名称 | Risperidon Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension |
---|
活性成分 | |
---|
剂型 | Powder and solvent for prolonged-release suspension for injection |
---|
上市许可持有人 | Teva B.V.
Swensweg 5
2031GA Haarlem
Netherlands |
---|
参考成员国 - 产品名称 | Austria (AT) Risperidon ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension |
---|
互认成员国 - 产品名称 | - Germany (DE)
Risperidon-ratiopharm 25 mg Pulver und Lösungsmittel zur Herstellung einer Depot-Injektionssuspension - Denmark (DK)
- Belgium (BE)
Risperidone Teva 25 mg Poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte - Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
Risperidone Teva GmbH - France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Sweden (SE)
- Norway (NO)
Risperidone Teva GmbH - Finland (FI)
- Poland (PL)
- Lithuania (LT)
Risperidone Teva 25 mg milteliai ir tirpiklis pailginto atpalaidavimo injekcinei suspensijai - Hungary (HU)
- Romania (RO)
Risperidonă Teva 25 mg pulbere și solvent pentru suspensie injectabilă cu eliberare prelungită
|
---|
许可日期 | 2020/10/14 |
---|
最近更新日期 | 2025/01/15 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Abridged
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|